ELS performs pioneering research on its own and through collaborations with leading academics around the world. ELS and its collaborators search for the underlying cause of life-threatening side effects that result from currently approved medications.
The figures below summarize ELS’ recent clinical and analytical work.
Drug-Drug and Drug-Disease Clinical Trials
Pharmacogenomic Trials
PBPK-Based Dosing
